Remove Article Remove BioTech Remove Health Policy Remove Patient Experience
article thumbnail

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

It is bittersweet to read the latter half of the title, as our friend and mentor Professor Reinhardt, a health economics pioneer, passed away last year. He co-wrote the first “It’s The Prices Stupid” research article in Health Affairs with Gerard Anderson et. Two news items illustrate this issue in real time.

BioTech 160
article thumbnail

Will Technology Cure Americans’ Health Care System Ills? Considering Google and Ascension Health’s Data Deal

Health Populi

You can read more details about this evolving situation in the WSJ article linked above, and other takes in tech, business, and social media that have begun to populate the interwebs. health care. Was this due to the growing experience and reporting of surprise medical bills?

BioTech 160
article thumbnail

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

To address that challenge, in 2017 PLM secured a $100 million (controlling interest) investment from iCarbonX , a Chinese company that is amassing patient data to discover cures for disease. When this occurred, it didn’t cause more than a ripple of interest outside biotech. Jane Sarasohn-Kahn Bio and her Blog, Health Populi.